LogoLogo
Principles and Practice of Drug Development 2023
  • Principles and Practice of Drug Development
  • News
  • Course Teaching Team
  • Course Logistics
  • Textbook and Reading Materials
  • Course Materials
  • Assignment Submission
  • Final Project Topic Selection
  • Course Photos
  • Funding and support
Powered by GitBook
On this page
  • 2024 Instructors and TAs
  • Guest Instructors
  • Past Instructors
  • Course Founders

Was this helpful?

Export as PDF

Course Teaching Team

PreviousNewsNextCourse Logistics

Last updated 8 months ago

Was this helpful?

2024 Instructors and TAs

(course co-director) is a Senior Research Scientist in MIT's Institute for Data, Systems and Society in the Schwarzman College of Computing and Associate Professor of Medicine at HMS and founding director of the MD/MBA joint degree program with Harvard Business School. His research focuses on the business-government interface, medical technology, cost-effectiveness and third-party reimbursement.

Raluca Cobzaru, BA (TA) is a PhD student in the Operations Research program at MIT. Her research is focused on developing robust models for causal inference with applications in drug repurposing.

Kayla Cruz, BS (TF) is a PhD candidate in the Biological and Biomedical Sciences (BBS) Program at Harvard. Her research is focused on examining the role of cytokines secreted by cancer-associated fibroblasts on tumor growth and drug resistance in pancreatic cancer.

Punya Gupta (TA) is an undergraduate at Harvard University concentrating in Molecular and Cellular Biology. Her research aims to better understand the role of a macrophage subset in pancreatic tumor development.

Guest Instructors

Past Instructors

Course Founders

Peter Sorger, PhD (course co-director) is a Professor in the Dept. of Systems Biology at Harvard Medical School (HMS) and founding Head of the Harvard Program in Therapeutic Science. He was previously on the MIT faculty as professor of Biology and Biological Engineering. focuses on mammalian signal transduction, cancer and its treatment.

(Instructor) is the Communication Lecturer and Communication Lab Manager in the Biological Engineering Department at MIT. Han has a background in biomedical engineering. In her current role, Han teaches science communication for BE students and postdocs and works with a team of trained communication fellows to support the community's communication needs.

, a former MIT graduate student, is Co-Founder and Chief Scientific Officer (CSO) of Applied Biomath, a startup company in Concord MA.

a former MIT postdoc, is Global Head of Modeling and Simulation and PK Sciences at Novartis Institutes for BioMedical Research (NIBR) in Cambridge MA.

is an Associate Professor of Business Administration in the Technology and Operations Management Unit at Harvard Business School.

is a Professor of Medicine at Brigham and Women's Hospital in Boston, MA and a a in the Thrombolysis in Myocardial Infarction () Study Group.

is a Managing Director at Credit Suisse Securities and expert in biotech financing.

is a Professor Emeritus of Chemical Engineering at MIT and a founder of PPDD.

is Executive Director of Pharmaceutical Manufacturing Initiatives at the .

is Clinical Director of the Center for Cutaneous Oncology at the Brigham and Women's Hospital.

is a Professor of Medicine at Harvard Medical School and Director of the Center for Sarcoma and Bone Oncology at the Dana-Farber Cancer Institute.

is Cheif Medical Officer (CMO) of Flagship Pioneering in Cambridge MA; he was previously CMO of Merck, Dean of Tufts University School of Medicine, and a Professor at Harvard Medical School.

is Chief Medical Officer of Foundation Medicine in Cambridge MA; he is an Associate Professor of Radiation Oncology at Harvard Medical School and the Dana-Farber Cancer Institute.

is the Global Head Infectious Diseases and Vice President at Roche.

is the William Bosworth Castle Professor of Medicine at Harvard Medical School and the Director of the Center for Virology and Vaccine Research at BIDMC

PPDD was established three decades ago by course founding directors: , , G. K. Raju, all of whom are still active as MIT Faculty. It has been taught continuously

Sorger's research
Han Xu, PhD
Joshua Apgar, PhD
Birgit Schoeberl, PhD,
Ariel Stern, PhD
Elliott Antman, MD
Senior Investigator
TIMI
Sumit Khedekar
Charles Cooney, PhD
GK Raju, PhD
MIT Center for Biomedical Innovation
Nicole LeBoeuf, MD, MPH
George Demetri, MD
Mike Rosenblatt, MD
Brian Alexander, MD, MPH
John Young, PhD,
Dan H. Barouch, MD, PhD
Thomas J. Allen
Charles L. Cooney
Anthony Sinskey
Stan Finkelstein, MD